microRNA-103 promotes LPS-induced inflammatory injury by targeting c-Myc in HK-2 cells

References

• Webster AC, Nagler EV, Morton RL, et al. Chronic kidney disease. Lancet. 2017;389:1238–1252.
   PubMed Web of Science ®Google Scholar
• Anders HJ, Andersen K, Stecher B. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int. 2013;83:1010–1016.
   PubMed Web of Science ®Google Scholar
• Ketteler M, Block GA, Evenepoel P, et al. Diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder: synopsis of the kidney disease: improving global outcomes 2017 clinical practice guideline update. Ann Intern Med. 2018;168:422–430.
   PubMed Web of Science ®Google Scholar
• Tucker PS, Scanlan AT, Dalbo VJ. Chronic kidney disease influences multiple systems: describing the relationship between oxidative stress, inflammation, kidney damage, and concomitant disease. Oxid Med Cell Longev. 2015;2015:1.
   Web of Science ®Google Scholar
• Yamamura S, Imai-Sumida M, Tanaka Y, et al. Interaction and cross-talk between non-coding RNAs. Cell Mol Life Sci. 2018;75:467–484.
   PubMed Web of Science ®Google Scholar
• Hulsmans M, De Keyzer D, Holvoet P. MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis. FASEB J. 2011;25:2515–2527.
   PubMed Web of Science ®Google Scholar
• Ellis KL, Cameron VA, Troughton RW, et al. Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients. Eur J Heart Fail. 2013;15:1138–1147.
   PubMed Web of Science ®Google Scholar
• Rossi AFT, Cadamuro ACT, Biselli‐Périco JM, et al. Interaction between inflammatory mediators and miRNAs in Helicobacter pylori infection. Cell Microbiol. 2016;18:1444–1458.
   PubMed Web of Science ®Google Scholar
• Kfir-Erenfeld S, Haggiag N, Biton M, et al. miR-103 inhibits proliferation and sensitizes hemopoietic tumor cells for glucocorticoid-induced apoptosis. Oncotarget. 2017;8:472.
   PubMedGoogle Scholar
• Porro A, Haber M, Diolaiti D, et al. Direct and coordinate regulation of ATP-binding cassette transporter genes by Myc factors generates specific transcription signatures that significantly affect the chemoresistance phenotype of cancer cells. J Biol Chem. 2010;285:19532–19543.
   PubMed Web of Science ®Google Scholar
• Yap CS, Peterson AL, Castellani G, et al. Kinetic profiling of the c-Myc transcriptome and bioinformatic analysis of repressed gene promoters. Cell Cycle (Georgetown, TX). 2011;10:2184–2196.
   PubMed Web of Science ®Google Scholar
• Liu H, Lu W, He H, et al. Inflammation-dependent overexpression of c-Myc enhances CRL4DCAF4 E3 ligase activity and promotes ubiquitination of ST7 in colitis-associated cancer. J Pathol. 2019.
   Web of Science ®Google Scholar
• Rong D, Sun H, Li Z, et al. An emerging function of circRNA-miRNAs-mRNA axis in human diseases. Oncotarget. 2017;8:73271–73281.
   PubMedGoogle Scholar
• Lin S, Gregory RI. MicroRNA biogenesis pathways in cancer. Nat Rev Cancer. 2015;15:321.
   PubMed Web of Science ®Google Scholar
• Lorenzen JM, Haller H, Thum T. MicroRNAs as mediators and therapeutic targets in chronic kidney disease. Nat Rev Nephrol. 2011;7:286–294.
   PubMed Web of Science ®Google Scholar
• Ichii O, Otsuka S, Sasaki N, et al. Altered expression of microRNA miR-146a correlates with the development of chronic renal inflammation. Kidney Int. 2012;81:280–292.
   PubMed Web of Science ®Google Scholar
• Ulbing M, Kirsch AH, Leber B, et al. MicroRNAs 223-3p and 93-5p in patients with chronic kidney disease before and after renal transplantation. Bone. 2017;95:115–123.
   PubMed Web of Science ®Google Scholar
• Natarelli L, Hartmann P, Wei Y, et al. MiR-103 target lncWDR59 to affect endothelial proliferation balanced by Notch1 and Wnt signaling co-activation. Atherosclerosis. 2017;263:e5.
   Web of Science ®Google Scholar
• Yoshida GJ, Saya H. Inversed relationship between CD44 variant and c-Myc due to oxidative stress-induced canonical Wnt activation. Biochem Biophys Res Commun. 2014;443:622–627.
   PubMed Web of Science ®Google Scholar
• Li H, Fang Y, Niu C, et al. Inhibition of cIAP1 as a strategy for targeting c-MYC-driven oncogenic activity. Proc Natl Acad Sci USA. 2018;115:E9317–E9324.
   Google Scholar
• Jackstadt R, Hermeking H. MicroRNAs as regulators and mediators of c-MYC function. Biochim Biophys Acta. 2015;1849:544–553.
   PubMed Web of Science ®Google Scholar
• Bai HY, Liao YJ, Cai MY, et al. Eukaryotic initiation factor 5A2 contributes to the maintenance of CD133 (+) hepatocellular carcinoma cells via the c-Myc/microRNA-29b axis. Stem Cells. 2018;36:180–191.
   PubMed Web of Science ®Google Scholar
• Colineau L, Lambertz U, Fornes O. c-Myc is a novel Leishmania virulence factor by proxy that targets the host miRNA system and is essential for survival in human macrophages. J Biol Chem. 2018;293:12805–12819.
   PubMed Web of Science ®Google Scholar
• Li M, Liu Y, Wei Y, et al. Zinc-finger protein YY1 suppresses tumor growth of human nasopharyngeal carcinoma by inactivating c-Myc-mediated microRNA-141 transcription. J Biol Chem. 2019;294:6172–6187.
   PubMed Web of Science ®Google Scholar
• Wang YB, Zhao XH, Li G, et al. MicroRNA-184 inhibits proliferation and promotes apoptosis of human colon cancer SW480 and HCT116 cells by downregulating C-MYC and BCL-2. J Cell Biochem. 2018;119:1702–1715.
   PubMed Web of Science ®Google Scholar
• Prashad N. miR-665 targets c-MYC and HDAC8 to inhibit murine neuroblastoma cell growth. Oncotarget. 2018;9:33186–33201.
   PubMedGoogle Scholar
• Nandi S, Salman M, Sharma A, et al. Signal transduction through JAK-STAT and NF-κB regulated Pim-1 kinase: novel target for anticancer leads. Curr Signal Transduct. 2018;13:83–104.
   Google Scholar
• Wu Z, Lu H, Sheng J, et al. Inductive microRNA-21 impairs anti-mycobacterial responses by targeting IL-12 and Bcl-2. FEBS Lett. 2012;586:2459–2467.
   PubMed Web of Science ®Google Scholar
• Wang X, Liu Q, Ihsan A, et al. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin. Toxicol Sci. 2012;127:412–424.
   PubMed Web of Science ®Google Scholar
• Chin MP, Bakris GL, Block GA, et al. Bardoxolone methyl improves kidney function in patients with chronic kidney disease stage 4 and type 2 diabetes: post-hoc analyses from bardoxolone methyl evaluation in patients with chronic kidney disease and type 2 diabetes study. Am J Nephrol. 2018;47:40–47.
   PubMed Web of Science ®Google Scholar
• Cruz KJC, de Oliveira ARS, Morais JBS, et al. Role of microRNAs on adipogenesis, chronic low-grade inflammation, and insulin resistance in obesity. Nutrition (Burbank, Los Angeles County, CA). 2017;35:28–35.
   PubMed Web of Science ®Google Scholar
• Liu L, Pang XL, Shang WJ, et al. Over-expressed microRNA-181a reduces glomerular sclerosis and renal tubular epithelial injury in rats with chronic kidney disease via down-regulation of the TLR/NF-kappaB pathway by binding to CRY1. Mol Med. 2018;24:49.
   PubMed Web of Science ®Google Scholar